Excipientes de medicamentos e as informações da bula


Autoria(s): Balbani, Aracy Pereira Silveira; Stelzer, Lucilena Bardella; Montovani, Jair Cortez
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

05/10/2006

Resumo

Aim: To evaluate the presence of preservatives, dyes, sweeteners and flavouring substances in 73 pharmaceutical preparations of 35 medicines for oral administration, according to drug labeling information about the excipients. Methods: 35 medications were selected, both over-the-counter and prescription durgs, marketed in Brazil. The sample included: analgesic/antipyretic, antimicrobial, mucoregulatory, cough and cold, decongestant, antihistamine, bronchodilator, corticosteroid, antiinflammatory and vitamin medications. We collected data on 73 preparations of these drugs, according to drug labeling information regarding preservatives, dyes, sweeteners and flavourings. Results: Methylparaben and propylparaben were the most common preservatives found (43% and 35.6% respectively). The most common sweeteners were: sucrose (sugar) (53.4%), sodium saccharin (38.3%) and sorbitol (36.9%). Twenty-one medicines (28,7%) contained two sweeteners. Colourless medicines predominated (43.8%), followed by those with sunset yellow dye (FD&C yellow no. 6) (15%). Five products (6.8%) contained more than one colour agent. Tartrazine (FD&C yellow no. 5) was present in seven preparations (9.5%). Fruit was the most common flavouring found (83%). Labelings of drugs which contained sugar frequently omitted its exact concentration (77%). Of the four labelings of medicines which contained aspartame, two did not warn patients regarding phenylketonuria. Conclusions: Omission and inacuracy of drug labeling information on pharmaceutical excipients may expose susceptible individuals to adverse reactions caused by preservatives and dyes. Complications of inadvertent intake of sugar-containing medicines by diabetics, or aspartame intake by patients with phenylketonuria may also occur.

Formato

400-406

Identificador

http://dx.doi.org/10.1590/S0034-72992006000300018

Revista Brasileira de Otorrinolaringologia, v. 72, n. 3, p. 400-406, 2006.

0034-7299

http://hdl.handle.net/11449/69158

10.1590/S0034-72992006000300018

S0034-72992006000300018

2-s2.0-33749161876

2-s2.0-33749161876.pdf

Idioma(s)

por

Relação

Revista Brasileira de Otorrinolaringologia

Direitos

openAccess

Palavras-Chave #Drug labeling #Flavoring agents #Parabens #Pharmaceutic aids #Pharmaceutical preservatives #Tartrazine #amoxicillin #analgesic agent #antihistaminic agent #antiinfective agent #antiinflammatory agent #antipyretic agent #aspartame #azithromycin #bronchodilating agent #cetirizine #coloring agent #corticosteroid #decongestive agent #drug additive #ebastine #epinastine #ibuprofen #loratadine #methyl paraben #nimesulide #paracetamol #preservative #propyl paraben #saccharin sodium #sorbitol #sucrose #sunset yellow #tartrazine #unindexed drug #vitamin #accuracy #Brazil #chemical composition #concentration (parameters) #consumer health information #drug formulary #drug information #drug labeling #phenylketonuria #Coloring Agents #Drug Labeling #Flavoring Agents #Humans #Pharmaceutic Aids #Pharmaceutical Preparations #Preservatives, Pharmaceutical #Sweetening Agents
Tipo

info:eu-repo/semantics/article